Kastritis, Efstathios <br/><br/>
Treatment of light chain (AL) amyloidosis with the combination of bortezomib and dexamethasone.  [electronic resource] 

 -  Haematologica  Oct 2007 
 - 1351-8 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article 
<br/><br/><label>ISSN: </label>1592-8721 
<br/><br/><label>Standard No.: </label>10.3324/haematol.11325  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Amyloidosis--classification<br/>Boronic Acids--adverse effects<br/>Bortezomib<br/>Dexamethasone--adverse effects<br/>Drug Therapy, Combination<br/>Female<br/>Humans<br/>Male<br/>Middle Aged<br/>Pyrazines--adverse effects<br/>Survival Rate<br/>Treatment Outcome